James M George

5PUBLICATIONS
47CO-AUTHORS
Predictive and prognostic markersMolecular targetsEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 03, 2025
Targeting histone H2B acetylated enhanceosomes via p300/CBP degradation in prostate cancer.

Jie Luo, Zhixiang Chen, Yuanyuan Qiao

|Jun 26, 2025
Divergent FOXA1 mutations drive prostate tumorigenesis and therapy-resistant cellular plasticity.

Sanjana Eyunni, Rahul Mannan, Yuping Zhang

|Sep 09, 2024
NSD2 is a requisite subunit of the AR/FOXA1 neo-enhanceosome in promoting prostate tumorigenesis.

Abhijit Parolia, Sanjana Eyunni, Brijesh Kumar Verma

|Apr 11, 2024
Enhancing NSCLC recurrence prediction with PET/CT habitat imaging, ctDNA, and integrative radiogenomics-blood insights.

Sheeba J Sujit, Muhammad Aminu, Tatiana V Karpinets

|Apr 21, 2023
Speed reading the epigenome and genome.

James M George, Arul M Chinnaiyan

Pageof 1